Why is testing for Clostridioides difficile important in an IBD patient on antibiotics?

• A. Antibiotics increase C. difficile risk; colitis can mimic IBD flare; testing guides antibiotic therapy
• B. C. difficile is not a concern in IBD
• C. Antibiotic side effects are the only concern
• D. C. difficile testing is only for hospital patients

Answer: (A)

Antibiotics disrupt the normal gut flora, which raises the risk of Clostridioides difficile infection. In someone with inflammatory bowel disease, C. difficile colitis can look very similar to an IBD flare, with diarrhea and abdominal pain, so testing helps tell apart infection from a flare and prevents treating a infection as if it were just inflammation. If the test is positive, you treat with targeted anti-C. difficile antibiotics and take steps to limit spread; if it’s negative, you avoid unnecessary anti-infective therapy and explore other causes of symptoms. It’s not something that only matters in hospitals—community-associated CDI can occur after outpatient antibiotic use as well, so testing is useful in both settings. This is why testing is important: it identifies a potentially dangerous infection that changes management and outcomes, rather than assuming every worsening symptom is just an IBD flare.